{"id":"therapeutic-platelet-transfusion","safety":{"commonSideEffects":[{"rate":"null","effect":"Bleeding"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This process can help prevent or treat bleeding disorders, such as thrombocytopenia, and reduce the risk of bleeding complications in patients undergoing surgery or with certain medical conditions.","oneSentence":"Therapeutic platelet transfusion involves administering platelets to a patient to increase their platelet count and improve blood clotting.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:38:31.160Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Thrombocytopenia"},{"name":"Bleeding disorders"}]},"trialDetails":[{"nctId":"NCT03910452","phase":"EARLY_PHASE1","title":"Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2019-10-28","conditions":"Chronic Granulomatous Disease","enrollment":4},{"nctId":"NCT05889494","phase":"NA","title":"Autologous Whole Blood Management for Transfusion Reduction in Adult Cardiac Surgery Patients","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2025-03-24","conditions":"Postoperative Hemorrhage, Postoperative Anemia, Postoperative Blood Loss","enrollment":64},{"nctId":"NCT06859424","phase":"PHASE2","title":"A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation","status":"RECRUITING","sponsor":"Center for International Blood and Marrow Transplant Research","startDate":"2025-07-25","conditions":"AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category)","enrollment":358},{"nctId":"NCT03587272","phase":"PHASE2","title":"Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease","status":"RECRUITING","sponsor":"Robert Nickel","startDate":"2018-04-17","conditions":"Sickle Cell Disease","enrollment":100},{"nctId":"NCT07441720","phase":"PHASE2","title":"Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT)","status":"RECRUITING","sponsor":"Zhejiang Cancer Hospital","startDate":"2026-02-28","conditions":"Thrombocytopenia, Cancer Treatment-induced Thrombocytopenia","enrollment":25},{"nctId":"NCT06070350","phase":"PHASE3","title":"Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children","status":"RECRUITING","sponsor":"Philip Spinella","startDate":"2024-11-01","conditions":"Hemorrhagic Shock, Trauma Injury","enrollment":1000},{"nctId":"NCT07400341","phase":"PHASE2","title":"Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AA","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2026-01-31","conditions":"MDS (Myelodysplastic Syndrome), Aplastic Anemia (AA)","enrollment":66},{"nctId":"NCT07230067","phase":"","title":"Sepsis-associated Thrombocytopenia and Platelet Transfusion （STAPT）","status":"RECRUITING","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2025-11-15","conditions":"Sepsis, Sepsis and Coagulopathy","enrollment":1500},{"nctId":"NCT07321626","phase":"PHASE1","title":"Romiplostim N01 for Platelet Recovery After Haploidentical HSCT","status":"RECRUITING","sponsor":"First Affiliated Hospital of Zhejiang University","startDate":"2025-06-01","conditions":"Acute Myeloid Leukemia, MDS (Myelodysplastic Syndrome), Delayed Platelet Engraftment","enrollment":130},{"nctId":"NCT04431999","phase":"PHASE3","title":"Evaluation of a Transfusion Therapy Using Whole Blood in the Management of Coagulopathy in Patients With Acute Traumatic Hemorrhage","status":"COMPLETED","sponsor":"Direction Centrale du Service de Santé des Armées","startDate":"2021-12-04","conditions":"Trauma, Acute Hemorrhage, Coagulopathy","enrollment":200},{"nctId":"NCT05399693","phase":"","title":"Platelet Transfusion Refractoriness","status":"COMPLETED","sponsor":"Institut de cancérologie Strasbourg Europe","startDate":"2022-02-02","conditions":"Platelet Transfusion Refractoriness","enrollment":50},{"nctId":"NCT05466201","phase":"PHASE2, PHASE3","title":"The Use of Eltrombopag Post HSCT in BMFD","status":"COMPLETED","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2022-10-22","conditions":"Stem Cell Transplant Complications","enrollment":118},{"nctId":"NCT02570542","phase":"PHASE2","title":"Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2015-10","conditions":"Diffuse Large B-cell Lymphoma (DLBCL), Relapsed Diffuse Large B-cell Lymphoma (DLBCL), Refractory Diffuse Large B-cell Lymphoma (DLBCL)","enrollment":59},{"nctId":"NCT07252375","phase":"PHASE2","title":"A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal Carcinoma","status":"NOT_YET_RECRUITING","sponsor":"Fujian Cancer Hospital","startDate":"2025-11-30","conditions":"Nasopharyngeal Carcinoma (NPC), CTIT-Chemotherapy Induced Thrombocytopenia","enrollment":35},{"nctId":"NCT06433622","phase":"","title":"Platelet Transfusion and Repeat TEG-PM in Patients With Severe TBI on Antiplatelet Therapy (Repeat TEG-PM)","status":"ENROLLING_BY_INVITATION","sponsor":"Lancaster General Hospital","startDate":"2023-12-01","conditions":"Traumatic Intracranial Hemorrhage","enrollment":225},{"nctId":"NCT03136445","phase":"PHASE3","title":"TRial to EvaluAte Tranexamic Acid Therapy in Thrombocytopenia","status":"COMPLETED","sponsor":"NHS Blood and Transplant","startDate":"2015-06","conditions":"Hematologic Neoplasms, Hemorrhage, Hematopoietic Stem Cell Transplantation","enrollment":616},{"nctId":"NCT05711485","phase":"NA","title":"Platelet-Directed Whole Blood Transfusion Strategy for Malaria","status":"RECRUITING","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2024-02-24","conditions":"Severe Malaria, Thrombocytopenia","enrollment":132},{"nctId":"NCT06043050","phase":"","title":"PRedicting OutcomeS in Preterm nEonates With thromboCyTopenia","status":"COMPLETED","sponsor":"Leiden University Medical Center","startDate":"2022-09-26","conditions":"Neonatal Thrombocytopenia, Intraventricular Hemorrhage, Platelet Transfusion","enrollment":1042},{"nctId":"NCT07129031","phase":"PHASE3","title":"Optimization Strategies for Blood Transfusion Protocols in the Emergency Treatment of Hemorrhagic Shock","status":"NOT_YET_RECRUITING","sponsor":"Xijing Hospital","startDate":"2025-09-01","conditions":"Hemorrhage, Hemorrhagic Shock, Upper Gastrointestinal Bleeding (UGIB)","enrollment":180},{"nctId":"NCT07127718","phase":"PHASE2","title":"Preventive Strategies for Early and Late Complications of Leptospirosis","status":"RECRUITING","sponsor":"National Kidney and Transplant Institute, Philippines","startDate":"2024-04-12","conditions":"Leptospirosis","enrollment":678},{"nctId":"NCT06650553","phase":"NA","title":"Umbilical Cord Blood-Supported Haplo-HSCT for Aplastic Anemia Treatment Study","status":"RECRUITING","sponsor":"Shanxi Bethune Hospital","startDate":"2024-06-01","conditions":"Aplastic Anemias","enrollment":110},{"nctId":"NCT05944458","phase":"PHASE4","title":"Efficacy of Intravenous N-Acetylcysteine in Preventing Linezolid-Induced Thrombocytopenia in Critically Ill Patients","status":"COMPLETED","sponsor":"Helwan University","startDate":"2023-08-01","conditions":"Linezolid, Antioxidant, Thrombocytopenia","enrollment":250},{"nctId":"NCT06483269","phase":"NA","title":"Homologus PRP in the Infiltrative Treatment of Knee Osteoarthritis in Young Athletic Patients","status":"RECRUITING","sponsor":"Istituto Ortopedico Rizzoli","startDate":"2023-10-10","conditions":"Knee Osteoarthritis","enrollment":30},{"nctId":"NCT06425614","phase":"NA","title":"COmbined pLaTelet and eRythrocyte AutotransfusioN During Cardiac surgEry (COLTRANE) Trial","status":"RECRUITING","sponsor":"University Hospital, Bordeaux","startDate":"2024-07-15","conditions":"On-pump Cardiac Surgery, High Risk for Bleeding, Autotransfusion","enrollment":570},{"nctId":"NCT06744777","phase":"PHASE3","title":"The Comparative Efficacy of Standard Treatment Plus Ribavirin vs Standard Treatment Alone in Preventing Clinically Significant Hemorrhage in Patients With Dengue Fever","status":"COMPLETED","sponsor":"Khyber Medical University Peshawar","startDate":"2024-12-17","conditions":"Dengue Fever, Dengue Hemorrhagic Fever, Severe Dengue","enrollment":284},{"nctId":"NCT05796557","phase":"PHASE4","title":"ECMO Hemostatic Transfusions in Children","status":"COMPLETED","sponsor":"Yale University","startDate":"2023-12-12","conditions":"Extracorporeal Membrane Oxygenation Complication, Hemorrhage, Thromboembolism","enrollment":50},{"nctId":"NCT06964971","phase":"NA","title":"Treatment of Transfusion-dependent Nonsevere Aplastic Anemia With Luspatercept: a Multicenter Prospective Clinical Study","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Zhejiang Chinese Medical University","startDate":"2025-05-20","conditions":"Transfusion-dependent Non-severe Aplastic Anemia","enrollment":90},{"nctId":"NCT03712618","phase":"PHASE2","title":"The SOLID Platelet Study","status":"TERMINATED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2019-06-10","conditions":"Platelet Transfusion Refractoriness (PTR), Thrombocytopenia","enrollment":2},{"nctId":"NCT04201704","phase":"NA","title":"Effect of Giving Reduced Fluid in Children After Trauma","status":"RECRUITING","sponsor":"Columbia University","startDate":"2018-08-27","conditions":"Critical Illness, Pediatrics, General Surgery","enrollment":250},{"nctId":"NCT06553833","phase":"","title":"Outcomes of Patient Blood Management in Patients Undergoing Major Surgery","status":"COMPLETED","sponsor":"Helios Klinik Gotha/Ohrdruf","startDate":"2024-09-01","conditions":"Major Surgery","enrollment":25979},{"nctId":"NCT03994783","phase":"PHASE3","title":"Transplant Antibody-Mediated Rejection: Guiding Effective Treatments","status":"TERMINATED","sponsor":"Imperial College London","startDate":"2019-07-17","conditions":"Kidney Transplant Rejection, Antibody-mediated Rejection","enrollment":3},{"nctId":"NCT05634109","phase":"PHASE3","title":"Whole Blood in Trauma Patients With Hemorrhagic Shock","status":"RECRUITING","sponsor":"Fundacion Clinica Valle del Lili","startDate":"2023-01-14","conditions":"Trauma, Trauma Injury, Trauma, Multiple","enrollment":220},{"nctId":"NCT05667805","phase":"PHASE4","title":"Coagulation in Cirrhosis","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2023-01-19","conditions":"Liver Cirrhosis","enrollment":400},{"nctId":"NCT01566695","phase":"PHASE3","title":"The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS)","status":"COMPLETED","sponsor":"Celgene","startDate":"2013-04-26","conditions":"Myelodysplastic Syndrome","enrollment":216},{"nctId":"NCT04667468","phase":"PHASE2","title":"Cold Stored Platelet in Hemorrhagic Shock","status":"COMPLETED","sponsor":"Jason Sperry","startDate":"2022-06-21","conditions":"Trauma, Hemorrhage","enrollment":200},{"nctId":"NCT06729320","phase":"NA","title":"A Randomized Controlled, Open, Single-center Clinical Study Evaluating the Efficacy and Safety of Umbilical Cord Blood Mononuclear Cells in Patients with Refractory Immune Effector Cell-related Hemocytopenia","status":"NOT_YET_RECRUITING","sponsor":"Beijing GoBroad Hospital","startDate":"2024-12-01","conditions":"Refractory Immune Effector Cell-related Hemocytopenia","enrollment":40},{"nctId":"NCT06613425","phase":"PHASE4","title":"Clinical Study of Combined Platelet Transfusion","status":"RECRUITING","sponsor":"The General Hospital of Western Theater Command","startDate":"2024-08-01","conditions":"Hematologic Diseases","enrollment":86},{"nctId":"NCT02907359","phase":"PHASE3","title":"Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAs","status":"COMPLETED","sponsor":"Astex Pharmaceuticals, Inc.","startDate":"2017-01-13","conditions":"Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic","enrollment":417},{"nctId":"NCT05293106","phase":"PHASE4","title":"Assessing the Hemostatic Efficacy of Pathogen Reduced Platelets in Children Undergoing Cardiopulmonary Bypass Surgery: A Pilot Clinical Trial","status":"TERMINATED","sponsor":"Weill Medical College of Cornell University","startDate":"2022-07-05","conditions":"Cardiopulmonary Bypass Surgery","enrollment":9},{"nctId":"NCT06535360","phase":"PHASE4","title":"Efficacy of Pathogen Inactivation Strategies for Platelet Transfusion","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2020-09-01","conditions":"Cardiopulmonary Bypass Surgery","enrollment":150},{"nctId":"NCT06345417","phase":"","title":"Outcomes of Patient Blood Management in Severely Anemic Patients","status":"NOT_YET_RECRUITING","sponsor":"Helios Klinik Gotha/Ohrdruf","startDate":"2024-04-01","conditions":"Severe Anemia","enrollment":20000},{"nctId":"NCT05581238","phase":"","title":"Validation of a Red Blood Cell Transfusion Prediction Model in a Low Transfusion Rate Population.","status":"COMPLETED","sponsor":"Medisch Spectrum Twente","startDate":"2022-11-01","conditions":"Platelet Aggregation, Blood Transfusion","enrollment":6428},{"nctId":"NCT04454723","phase":"NA","title":"Impact of Palliative Transfusions on Quality of Life in Patients With Blood Cancers on Hospice","status":"COMPLETED","sponsor":"University of Oklahoma","startDate":"2020-08-14","conditions":"Hematologic Malignancy","enrollment":20},{"nctId":"NCT04478123","phase":"PHASE2","title":"Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2020-07-14","conditions":"Multiple Myeloma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma","enrollment":62},{"nctId":"NCT06254560","phase":"PHASE2","title":"Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2023-02-23","conditions":"Severe Aplastic Anemia, Platelet Transfusion Refractoriness","enrollment":20},{"nctId":"NCT06095648","phase":"NA","title":"Study Comparing Platelet Transfusion Volumes in Premature Babies","status":"NOT_YET_RECRUITING","sponsor":"University College Dublin","startDate":"2023-10-28","conditions":"Thrombocytopenia, Transfusion","enrollment":370},{"nctId":"NCT05944211","phase":"PHASE2","title":"Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia(CIT) in Patients With Acute Myeloid Leukemia","status":"NOT_YET_RECRUITING","sponsor":"RenJi Hospital","startDate":"2023-07","conditions":"Chemotherapy-Induced Thrombocytopenia","enrollment":72},{"nctId":"NCT05038722","phase":"","title":"Function of Platelets Used for Transfusions","status":"ENROLLING_BY_INVITATION","sponsor":"Sofia Ramström","startDate":"2018-11-22","conditions":"Thrombocytopenia, Hematologic Malignancy","enrollment":240},{"nctId":"NCT00003138","phase":"PHASE3","title":"Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes","status":"COMPLETED","sponsor":"Eastern Cooperative Oncology Group","startDate":"1998-03-04","conditions":"Anemia, Myelodysplastic Syndromes","enrollment":118},{"nctId":"NCT01264315","phase":"PHASE2","title":"Safety And Efficacy Of Lenalidomide As Maintenance Therapy In Patients With Newly Diagnosed Multiple Myeloma Following A Tandem Autologous-Allogeneic Transplant","status":"COMPLETED","sponsor":"Fondazione EMN Italy Onlus","startDate":"2008-09","conditions":"Multiple Myeloma","enrollment":53},{"nctId":"NCT02613377","phase":"","title":"Transfusion-related Acute Lung Injury: a Prospective Cohort Study in Critically Ill Children","status":"COMPLETED","sponsor":"St. Justine's Hospital","startDate":"2016-01","conditions":"Acute Lung Injury","enrollment":717},{"nctId":"NCT05761457","phase":"NA","title":"Efficacy and Safety of Autologous Cryopreserved Platelets in Patients With PTR","status":"UNKNOWN","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2023-03-01","conditions":"Platelet Transfusion Refractoriness","enrollment":25},{"nctId":"NCT03045068","phase":"PHASE4","title":"Platelet Transfusion During Neonatal Open Heart Surgery","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2017-04-11","conditions":"Cardiac Disease, Cardiac Surgery, Cardiopulmonary Bypass","enrollment":46},{"nctId":"NCT05727917","phase":"NA","title":"Hetrombopag for the Enhancement of Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation","status":"UNKNOWN","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2023-01-01","conditions":"Hematological Disease, Allogeneic Hematopoietic Stem Cell Transplantation","enrollment":78},{"nctId":"NCT04155775","phase":"NA","title":"Effects of a Platelet Transfusion Best Practices Alert","status":"COMPLETED","sponsor":"Stanford University","startDate":"2019-05-09","conditions":"Thrombocytopenia","enrollment":446},{"nctId":"NCT04534751","phase":"PHASE4","title":"Factor In the Initial Resuscitation of Severe Trauma 2 Patients","status":"UNKNOWN","sponsor":"University Health Network, Toronto","startDate":"2021-04-01","conditions":"Traumatic Hemorrhage, Coagulopathy, Massive Hemorrhage","enrollment":350},{"nctId":"NCT04915287","phase":"PHASE4","title":"Efficacy of Avatrombopag in Thrombocytopenic Patients With Chronic Liver Disease Undergoing an Elective Procedure","status":"UNKNOWN","sponsor":"Chinese PLA General Hospital","startDate":"2021-06-06","conditions":"Thrombocytopenia; Drugs, Chronic Liver Disease","enrollment":476},{"nctId":"NCT04988620","phase":"NA","title":"Cold Stored Whole Blood in Cardiothoracic Surgery","status":"UNKNOWN","sponsor":"Haukeland University Hospital","startDate":"2021-06-04","conditions":"Bleeding","enrollment":80},{"nctId":"NCT02074436","phase":"PHASE2","title":"PRevention Of BLeeding in hEmatological Malignancies With Antifibrinolytic (Epsilon Aminocaproic Acid)","status":"TERMINATED","sponsor":"Emory University","startDate":"2014-05-23","conditions":"Hematological Malignancies, Thrombocytopenia","enrollment":29},{"nctId":"NCT05162378","phase":"","title":"Amotosalen and Platelet Transfusion in Adult Heart Surgery","status":"UNKNOWN","sponsor":"University Hospital, Strasbourg, France","startDate":"2020-10-21","conditions":"Heart Surgery","enrollment":100},{"nctId":"NCT04312789","phase":"PHASE2","title":"Avatrombopag for the Treatment of Thrombocytopenia After Donor Hematopoietic Stem Cell Transplant","status":"WITHDRAWN","sponsor":"Ayman Saad","startDate":"2022-12","conditions":"Platelet Disorder","enrollment":""},{"nctId":"NCT05135442","phase":"PHASE4","title":"Efficacy and Safety of Bortezomib as First-line Treatment of Acquired TTP","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2021-12-01","conditions":"Thrombotic Thrombocytopenic Purpura, Acquired","enrollment":30},{"nctId":"NCT05128084","phase":"","title":"Amotosalen and Platelet Transfusion in Pediatric Heart Surgery","status":"UNKNOWN","sponsor":"University Hospital, Strasbourg, France","startDate":"2020-10-01","conditions":"Congenital Heart Disease in Children","enrollment":50},{"nctId":"NCT05111028","phase":"PHASE1, PHASE2","title":"Reversal of Aspirin Antiplatelet Therapy With Cold Stored Platelets","status":"UNKNOWN","sponsor":"Bloodworks","startDate":"2020-11-20","conditions":"Reversal of Platelet Aggregation Inhibitors","enrollment":10},{"nctId":"NCT04846439","phase":"PHASE1, PHASE2","title":"Sequential Infusion of CD19 and BCMA CAR-T Cells to Improve PTR in Patients With AL","status":"UNKNOWN","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2021-04-29","conditions":"Platelet Transfusion Refractoriness, Acute Leukemia in Remission","enrollment":20},{"nctId":"NCT05067608","phase":"PHASE1, PHASE2","title":"Study on the Safety and Efficacy of Cryopreserved Platelets in Hypoproliferative Thrombocytopenic Patients","status":"COMPLETED","sponsor":"Singapore General Hospital","startDate":"2019-10-25","conditions":"Hypoproliferative Thrombocytopenia","enrollment":17},{"nctId":"NCT03090919","phase":"NA","title":"The INFUSE Trial - Intervening With Platelet Transfusions in Sepsis","status":"WITHDRAWN","sponsor":"Susan Smyth","startDate":"2017-01-03","conditions":"Sepsis, Thrombocytopenia","enrollment":""},{"nctId":"NCT04949698","phase":"","title":"Risk Factors and the Effect of Plasma Exchange on Prognosis of Pregnancy-related Thrombotic Microangiopathies","status":"UNKNOWN","sponsor":"Peking University Third Hospital","startDate":"2021-08-01","conditions":"Pregnancy-related Thrombotic Microangiopathies","enrollment":50},{"nctId":"NCT02495506","phase":"NA","title":"Transfusion of Cold-stored Platelet Concentrates","status":"COMPLETED","sponsor":"Haukeland University Hospital","startDate":"2015-03","conditions":"Cardiovascular Disease Other, Bleeding, Surgery","enrollment":65},{"nctId":"NCT04807621","phase":"PHASE2","title":"Platelets or Fibrinogen as First-line Treatment for Bleeding During Pedatric Heart Surgery","status":"UNKNOWN","sponsor":"Sahlgrenska University Hospital","startDate":"2018-03-14","conditions":"Congenital Heart Disease","enrollment":40},{"nctId":"NCT04797182","phase":"PHASE2","title":"Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2021-04","conditions":"Thrombocytopenia, Cytarabine Causing Adverse Effects in Therapeutic Use, Lymphoma","enrollment":46},{"nctId":"NCT03380767","phase":"NA","title":"Use of Viscoelastic Tests in the Treatment of Traumatic Induced Coagulopathy: a Pragmatic Randomized Clinical Trial.","status":"WITHDRAWN","sponsor":"A.O. Ospedale Papa Giovanni XXIII","startDate":"2019-12","conditions":"Trauma, Multiple, Coagulopathy, Massive Hemorrhage","enrollment":""},{"nctId":"NCT03823352","phase":"PHASE2","title":"Evaluate Efficacy and Safety/Tolerability Profiles of Antroquinonol in Acute Myeloid Leukemia (AML) Adult Patients","status":"COMPLETED","sponsor":"Golden Biotechnology Corporation","startDate":"2019-02-20","conditions":"Leukemia, Myeloid, Acute","enrollment":12},{"nctId":"NCT02457403","phase":"NA","title":"Comparison of Blood Product Use and Bleeding Events During and After Endoscopic or Neurosurgical Procedures in Patients With Cirrhosis and Coagulopathy","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2015-05","conditions":"Cirrhosis, Coagulopathy","enrollment":68},{"nctId":"NCT04715360","phase":"PHASE1, PHASE2","title":"Management of Cytokine Storms in Severe COVID-19 Patients With Autologous Activated Platelet-rich Plasma Therapy","status":"UNKNOWN","sponsor":"Hayandra Peduli Foundation","startDate":"2020-12-29","conditions":"Covid19, Sars-CoV-2 Infection, ARDS, Human","enrollment":30},{"nctId":"NCT03973021","phase":"PHASE1, PHASE2","title":"Very Small Embryonic-like Stem Cells for Erectile Dysfunction","status":"WITHDRAWN","sponsor":"Fuda Cancer Hospital, Guangzhou","startDate":"2019-07-01","conditions":"Organic Erectile Dysfunction","enrollment":""},{"nctId":"NCT04564651","phase":"NA","title":"Platelet Transfusion in Acute-on Chronic Liver Failure","status":"UNKNOWN","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2019-05-01","conditions":"Acute-On-Chronic Liver Failure","enrollment":80},{"nctId":"NCT03391856","phase":"PHASE2, PHASE3","title":"Prolonged Isolated Thrombocytopenia After Allo-SCT : N-acetyl-L-cysteine (NAC) Versus Supportive Therapy","status":"TERMINATED","sponsor":"Peking University People's Hospital","startDate":"2018-03-01","conditions":"Thrombocytopenia, Stem Cell Transplant Complications","enrollment":15},{"nctId":"NCT03288441","phase":"","title":"Management and Outcomes of Anti-thrombotic Medication Use in Thrombocytopenia","status":"UNKNOWN","sponsor":"Maastricht University Medical Center","startDate":"2018-03-20","conditions":"Hematologic Neoplasms, Thrombocytopenia, Anticoagulants","enrollment":300},{"nctId":"NCT04492501","phase":"NA","title":"Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan","status":"COMPLETED","sponsor":"UNICEF","startDate":"2020-04-01","conditions":"Covid19, Cytokine Release Syndrome, Critical Illness","enrollment":600},{"nctId":"NCT03787927","phase":"PHASE1, PHASE2","title":"Reversal of Dual Antiplatelet Therapy With Cold Stored Platelets","status":"UNKNOWN","sponsor":"Bloodworks","startDate":"2018-12-03","conditions":"Bleeding, Platelet Dysfunction Due to Drugs, Platelet Dysfunction","enrollment":60},{"nctId":"NCT01490723","phase":"PHASE2","title":"Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2013-01","conditions":"Leukemia, Lymphoma","enrollment":20},{"nctId":"NCT03968484","phase":"NA","title":"Platelet Transfusion in Sepsis Trial","status":"WITHDRAWN","sponsor":"University Hospital Tuebingen","startDate":"2020-08-01","conditions":"Sepsis, Thrombocytopenia","enrollment":""},{"nctId":"NCT02461251","phase":"NA","title":"Thromboelastometry-guided Treatment Protocol Versus Standard Care of Major Haemorrhage in Obstetric Patients","status":"COMPLETED","sponsor":"Tampere University Hospital","startDate":"2016-01","conditions":"Obstetric Labor Complications, Hemorrhage","enrollment":59},{"nctId":"NCT03195010","phase":"PHASE2","title":"Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia","status":"TERMINATED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2017-06-09","conditions":"Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia","enrollment":4},{"nctId":"NCT00742001","phase":"PHASE1","title":"Feasibility Study of Mirasol-Treated Whole Blood Red Cell Recovery and Survival","status":"TERMINATED","sponsor":"Terumo BCTbio","startDate":"2008-09-10","conditions":"Healthy","enrollment":12},{"nctId":"NCT01358734","phase":"PHASE2","title":"A Study Being Conducted at Multiple Locations to Compare Safety and Efficacy of Three Different Regimens; (1) High-Dose Lenalidomide; (2) Lenalidomide + Azacitidine; or (3) Azacitidine in Subjects ≥ 65 Years With Newly-Diagnosed Acute Myeloid Leukemia","status":"COMPLETED","sponsor":"Celgene","startDate":"2012-04-27","conditions":"Acute Myeloid Leukemia, Acute Myelogenous Leukemia","enrollment":88},{"nctId":"NCT03561909","phase":"NA","title":"Kinetics of Blood Platelets Transfused to Healthy Subjects","status":"COMPLETED","sponsor":"Prophylix Pharma AS","startDate":"2018-04-17","conditions":"Fetal and Neonatal Alloimmune Thrombocytopenia","enrollment":25},{"nctId":"NCT01536496","phase":"NA","title":"Comparison of Rapid Thrombelastography and Conventional Coagulation Testing for Haemostatic Resuscitation in Trauma","status":"COMPLETED","sponsor":"Denver Health and Hospital Authority","startDate":"2010-09","conditions":"Acute Coagulopathy","enrollment":114},{"nctId":"NCT03282201","phase":"","title":"A Survey on Blood Transfusions in Major Artrhoplasty Operations","status":"COMPLETED","sponsor":"Diskapi Teaching and Research Hospital","startDate":"2017-10-15","conditions":"Arthropathy of Hip, Arthropathy of Knee","enrollment":418},{"nctId":"NCT02305732","phase":"","title":"A Prospective, Open Label, Treatment Use Study of Patient Safety Following Transfusion of INTERCEPT Platelet Components","status":"COMPLETED","sponsor":"Cerus Corporation","startDate":"2015-03","conditions":"Chikungunya Virus, Dengue Virus","enrollment":90},{"nctId":"NCT03713489","phase":"NA","title":"Platelet Transfusion in HBV-related acute-on Chronic Liver Failure","status":"UNKNOWN","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2018-10-01","conditions":"Acute-On-Chronic Liver Failure","enrollment":20},{"nctId":"NCT03701217","phase":"PHASE2, PHASE3","title":"Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AML","status":"UNKNOWN","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2018-09-10","conditions":"Eltrombopag, Thrombocytopenia, Acute Myeloid Leukemia","enrollment":220},{"nctId":"NCT02593877","phase":"PHASE2","title":"Implementing Treatment Algorithms for the Correction of Trauma Induced Coagulopathy","status":"COMPLETED","sponsor":"Queen Mary University of London","startDate":"2016-06-01","conditions":"Hemorrhage, Coagulopathy, Trauma","enrollment":412},{"nctId":"NCT01283321","phase":"PHASE2","title":"RiaSTAP vs. Conventional Transfusion in Patients Having Heart Valve Surgery","status":"TERMINATED","sponsor":"Emory University","startDate":"2011-01","conditions":"Heart Valve Disease, Coronary Artery Disease","enrollment":26},{"nctId":"NCT03275077","phase":"","title":"To Compare TEG (Thrombelastography) and Conventional Tests in CKD Patients","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2016-03-12","conditions":"End Stage Renal Disease, Coagulopathy","enrollment":100},{"nctId":"NCT01227005","phase":"PHASE4","title":"Early Whole Blood in Patients Requiring Transfusion After Major Trauma","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2011-05","conditions":"Trauma/Injury Problem","enrollment":107},{"nctId":"NCT03515447","phase":"","title":"Romiplostim in Thoracic Transplantation","status":"COMPLETED","sponsor":"Nantes University Hospital","startDate":"2014-05-01","conditions":"Thrombocytopenia","enrollment":30},{"nctId":"NCT03444077","phase":"NA","title":"Impact of a Prehospital Identification of Trauma Patients in Need for Damage Control Resuscitation.","status":"UNKNOWN","sponsor":"University of Liege","startDate":"2018-07","conditions":"Trauma, Coagulopathy, Hemorrhage","enrollment":400},{"nctId":"NCT03492515","phase":"PHASE3","title":"Recombinant Human Thrombopoietin(rhTPO) in Pregnancy With Immune Thrombocytopenia","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2018-05-01","conditions":"Immune Thrombocytopenia","enrollment":90}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":17,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Therapeutic platelet transfusion","genericName":"Therapeutic platelet transfusion","companyName":"Technische Universität Dresden","companyId":"technische-universit-t-dresden","modality":"Biologic","firstApprovalDate":"","aiSummary":"Therapeutic platelet transfusion involves administering platelets to a patient to increase their platelet count and improve blood clotting. Used for Thrombocytopenia, Bleeding disorders.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}